Compare with IOL CHEMICALS & PHARM. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs IOL CHEMICALS & PHARM. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS IOL CHEMICALS & PHARM. SUVEN PHARMACEUTICALS/
IOL CHEMICALS & PHARM.
 
P/E (TTM) x 42.2 8.5 494.8% View Chart
P/BV x 11.0 2.6 424.8% View Chart
Dividend Yield % 0.4 1.1 36.3%  

Financials

 SUVEN PHARMACEUTICALS   IOL CHEMICALS & PHARM.
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
IOL CHEMICALS & PHARM.
Mar-21
SUVEN PHARMACEUTICALS/
IOL CHEMICALS & PHARM.
5-Yr Chart
Click to enlarge
High Rs525898 58.5%   
Low Rs103175 59.0%   
Sales per share (Unadj.) Rs39.7335.0 11.8%  
Earnings per share (Unadj.) Rs12.175.7 16.0%  
Cash flow per share (Unadj.) Rs13.482.4 16.2%  
Dividends per share (Unadj.) Rs2.006.00 33.3%  
Avg Dividend yield %0.61.1 56.9%  
Book value per share (Unadj.) Rs46.4214.7 21.6%  
Shares outstanding (eoy) m254.5758.71 433.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.91.6 494.6%   
Avg P/E ratio x25.97.1 365.7%  
P/CF ratio (eoy) x23.56.5 360.8%  
Price / Book Value ratio x6.82.5 271.0%  
Dividend payout %16.57.9 208.2%   
Avg Mkt Cap Rs m79,95331,493 253.9%   
No. of employees `000NANA-   
Total wages/salary Rs m7621,156 66.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,09719,670 51.3%  
Other income Rs m142243 58.6%   
Total revenues Rs m10,24019,913 51.4%   
Gross profit Rs m4,4305,918 74.9%  
Depreciation Rs m316389 81.3%   
Interest Rs m11758 200.1%   
Profit before tax Rs m4,1395,714 72.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0531,268 83.0%   
Profit after tax Rs m3,0864,446 69.4%  
Gross profit margin %43.930.1 145.8%  
Effective tax rate %25.422.2 114.6%   
Net profit margin %30.622.6 135.2%  
BALANCE SHEET DATA
Current assets Rs m6,66511,645 57.2%   
Current liabilities Rs m3,2154,328 74.3%   
Net working cap to sales %34.237.2 91.9%  
Current ratio x2.12.7 77.0%  
Inventory Days Days2005 3,793.1%  
Debtors Days Days3706 6,641.3%  
Net fixed assets Rs m9,0975,878 154.8%   
Share capital Rs m255587 43.4%   
"Free" reserves Rs m11,55412,017 96.1%   
Net worth Rs m11,80812,604 93.7%   
Long term debt Rs m3560-   
Total assets Rs m15,76217,523 89.9%  
Interest coverage x36.599.0 36.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.1 57.1%   
Return on assets %20.325.7 79.1%  
Return on equity %26.135.3 74.1%  
Return on capital %35.045.8 76.4%  
Exports to sales %026.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA5,272 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,9025,272 187.8%   
Fx outflow Rs m1,3695,004 27.4%   
Net fx Rs m8,533268 3,190.1%   
CASH FLOW
From Operations Rs m3,8343,798 101.0%  
From Investments Rs m-3,114-3,173 98.2%  
From Financial Activity Rs m-766-583 131.4%  
Net Cashflow Rs m-4543 -106.2%  

Share Holding

Indian Promoters % 60.0 43.7 137.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 13.8 3.1 443.6%  
FIIs % 8.0 2.8 290.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 56.3 71.0%  
Shareholders   96,532 142,022 68.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   FERMENTA BIOTECH  CIAN HEALTHCARE  ZOTA HEALTH CARE  HINDUSTAN BIOSCIE  CADILA HEALTHCARE  



Today's Market

Sensex Down 400 Points, Nifty Below 18,100; Adani Ports & Titan Among Top Losers(10:30 am)

Asian share markets are lower today, extending falls on Wall Street as investors awaited a monetary policy decision from the Bank of Japan and European Central Bank (ECB) later in the day.

Related Views on News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

IOL CHEMICALS & PHARM. 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IOL CHEMICALS & PHARM. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IOL CHEMICALS & PHARM.. Also includes updates on the valuation of IOL CHEMICALS & PHARM..

IOL CHEMICALS & PHARM. Announces Quarterly Results (1QFY22); Net Profit Down 47.5% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, IOL CHEMICALS & PHARM. has posted a net profit of Rs 670 m (down 47.5% YoY). Sales on the other hand came in at Rs 5 bn (up 12.7% YoY). Read on for a complete analysis of IOL CHEMICALS & PHARM.'s quarterly results.

More Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status(Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies(Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs(Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN PHARMACEUTICALS SHARE PRICE


Oct 28, 2021 01:21 PM

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 8-QTR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS